Search This Blog

Tuesday 20 September 2016

Register for EACPT Focus Meeting in Opatija, Croatia on How to Assess Medicines 6th - 9th October


There is still time to register for the next EACPT Focus Meeting which will be held from 6th to 9th October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics.

The theme of the meeting is “How to Assess Medicines from Research to Clinical Practice”.

There is a bursary fund of 10,000 € to support abstract presenters.

Key dates

 
The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner.
The meeting will include a combination of scientific podium lectures, interactive workshops and guided poster sessions covering three main pillars important for the critical assessment of medicinal products - efficacy, effectiveness, and economics (3E assessment).

There will be a dedicated session for Young Pharmacologists during the meeting. There will be an EACPT Scientific Communication Award for the best presentation by a young scientist. 
Confirmed speakers and topics

JANNE TAPIO BACKMAN (Finland): Clinical drug-drug interaction studies: methods, pitfalls and interpretation
NADA BOŽINA (Croatia): The role of pharmacogenetics in individulized treatment choices
YLVA BOTTIGER (Sweden): National model for the introduction and follow-up of new, expensive drugs in Sweden
GONZALO CALVO (Spain): Accelerated approval paths. What they do mean and what they should not mean?
SIMON MAXWELL (UK): Safe introduction of new medicines into clinical practice
KEN PATERSON (UK): Rapid Health Technology Assessment of New Medicines - Lessons from 15 Years Experience in Scotland
WORKSHOP 2: EXCELLENCE IN CLINICAL RESEARCH - CLINICAL TRIAL DESIGN
IGOR FRANCETIĆ (Croatia): Effectiveness assessment: when pharmacokinetics makes a difference / macrolide and azalide examples
MATTHIAS SCHWAB (Germany): Pharmacogenomics and drug response: future challenges
EDUARDO SPINA (Italy): Efficacy of antidepressants: issues related to bias in clinical trials
TABASSOME SIMON (France): Key points for building succesful clinical trial
SINIŠA TOMIĆ (Croatia): The Role of the National Competent Authority (NCA) in the Assessment of Medicinal Products in the National Procedure
DONALD SINGER (UK): Personalised medicine approaches for identifying effective therapies
SLOBODAN VUKIČEVIĆ (Croatia): Current challenges and hurdles in new drug development

We will be guests in the Adriatic coastal town Opatija, Croatia. Opatija lies at the centre of the Kvarner Riviera with the longest tradition of providing quality conference venues in Croatia. Opatija’s very attractive geographic location, lush green scenery and a pleasant climate (45° 20’ north latitude) were some of the main reasons for its origins and the rapid development of its tourism from the end of the 19th century.  The venue – Grand Hotel 4 Opatijska Cvijeta –  is located in the very centre of Opatija and includes four buildings that were named after Opatija’s best-known flowers. The hotel has 223 rooms. The hotel also includes the large Tamaris congress centre, which has 7 multi-functional halls and the latest congress equipment.

Anyone from anywhere in the world with a professional interest in clinical pharmacology
and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:
  • Discounted registration fees for EACPT meetings
  • Online access to the Official EACPT Journal - Clinical Therapeutics
  • Access to the EACPT’s worldwide network of Individual Associate Members
  • Active involvement in EACPT 
The EACPT was founded 24 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

No comments:

Post a Comment